Practice variation in physician referral for allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 48, Issue 1, 2013, Pages 63-67

  Pidala, J ^a   Craig, B M ^a   Lee, S J ^b   Majhail, N ^c   Quinn, G ^a   Anasetti, C ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Health disparities; Hematopoietic cell transplantation; Physician survey

Indexed keywords

ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMORBIDITY; FEMALE; HEALTH CARE ACCESS; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; MALE; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL SUPPORT; TREATMENT INDICATION;

ADULT; AFRICAN AMERICANS; AGE FACTORS; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HEMATOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; LEUKEMIA; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION; SOCIAL SUPPORT; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 84872135149     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.95     Document Type: Article

References (29)

1. Anasetti C, Hillgruber R, Nye V, Ayala E, Kharfan-Dabaja M, Fernandez H et al. Patient ethnicity markedly affects the probability of finding an HLA-A, B, C, and DRB1 allele matched unrelated donor for hemopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 16: S172.
2. Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JD. Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 2010; 16: 1070-1075.
3. Cho C. Factors affecting stem cell transplantation for leukemia and lymphoma. Available at http://hdl.handle.net/1961/3595.
4. Hwang JP, Lam TP, Cohen DS, Donato ML, Geraci JM. Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas. Cancer 2004; 101: 2230-2238. (Pubitemid 39458678)
5. Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR. Access to stem cell transplantation: do women fare as well as men? Am J Hematol 2003; 72: 99-102. (Pubitemid 36164343)
6. Mitchell JM, Meehan KR, Kong J, Schulman KA. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol 1997; 15: 2644-2651. (Pubitemid 27289896)
7. Joshua T, Rizzo JD, Zhang MJ, Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and gender (abstract). Biol Blood Marrow Transplant 2007; 13(Suppl): 22.
8. Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15: 1543-1554.
9. Baker KS, Loberiza Jr. FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol 2005; 23: 7032-7042.
10. Serna DS, Lee SJ, Zhang MJ, Baker S, Eapen M, Horowitz MM et al. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol 2003; 21: 3754-3760. (Pubitemid 46606229)
11. Silla L, Fischer GB, Paz A, Daudt LE, Mitto I, Katz B et al. Patient socioeconomic status as a prognostic factor for allo-SCT. Bone Marrow Transplant 2009; 43: 571-577.
12. Flynn TN, Louviere JJ, Peters TJ, Coast J. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ 2007; 26: 171-189. (Pubitemid 44908719)
13. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997; 50: 1129-1136. (Pubitemid 27477990)
14. McCloskey SA, Tao ML, Rose CM, Fink A, Amadeo AM. National survey of perspectives of palliative radiation therapy: role, barriers, and needs. Cancer J 2007; 13: 130-137.
15. Thorpe C, Ryan B, McLean SL, Burt A, Stewart M, Brown JB et al. How to obtain excellent response rates when surveying physicians. Fam Pract 2009; 26: 65-68.
16. Dillman DA. Mail and telephone surveys: the total design method. In: Sons JWa (ed). Wiley, New York, 1978.
17. Field TS, Cadoret CA, Brown ML, Ford M, Greene SM, Hill D et al. Surveying physicians: do components of the 'Total Design Approach' to optimizing survey response rates apply to physicians? Med Care 2002; 40: 596-605.
18. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R et al. Methods to increase response rates to postal questionnaires. Cochrane Database Syst Rev 2007; 2: MR000008.
19. Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK et al. HLAidentical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol 2009; 27: 1644-1652.
20. Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood 2010; 116: 1839-1848.
21. Hows JM, Passweg JR, Tichelli A, Locasciulli A, Szydlo R, Bacigalupo A et al. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant 2006; 38: 799-805. (Pubitemid 44830839)
22. Moore J, Nivison-Smith I, Goh K, Ma D, Bradstock K, Szer J et al. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 2007; 13: 601-607. (Pubitemid 46585933)
23. Ringden O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D et al. The graftversus-leukemia effect using matched unrelated donors is not superior to HLAidentical siblings for hematopoietic stem cell transplantation. Blood 2009; 113: 3110-3118.
24. Schetelig J, Bornhauser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol 2008; 26: 5183-5191.
25. Walter RB, Pagel JM, Gooley TA, Petersdorf EW, Sorror ML, Woolfrey AE et al. Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission. Leukemia 2010; 24: 1276-1282.
26. Weisdorf DJ, Anasetti C, Antin JH, Kernan NA, Kollman C, Snyder D et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 2002; 99: 1971-1977. (Pubitemid 34525477)
27. Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH et al. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graftversus-host disease but not less relapse. Biol Blood Marrow Transplant 2009; 15: 1475-1478.
28. Gratwohl A, Schmid O, Baldomero H, Horisberger B, Urbano-Ispizua A. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey. Bone Marrow Transplant 2004; 34: 855-875. (Pubitemid 39562136)
29. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919. (Pubitemid 41510773)